Eosinophil to lymphocyte ratio may predict OCS reduction and change in quality of life (AQLQ) resulting from asthma biological treatment

CONCLUSIONS: Pre-treatment eosinophil-to-lymphocyte ratio may predict oral corticosteroid dose reduction resulting from omalizumab treatment and change in quality of life and asthma control resulting from anti-IL-5 and IL-5R treatment.PMID:38151952 | DOI:10.1080/08923973.2023.2300300
Source: Immunopharmacology and Immunotoxicology - Category: Allergy & Immunology Authors: Source Type: research